Medical Condition News

RSS

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

HTX, a member of the Canadian Venture Capital Association, announced today it provided $750,000 in financing to Profound Medical Inc. through their Technology Assessment Program.

15 Jun 2011

ESC publishes position paper to raise the profile of vulnerable plaques

The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

15 Jun 2011

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

A type of virus known as the human reovirus possesses a remarkable trait: It can replicate inside and kill cancer cells that feature a common mutation, while leaving the body's normal cells alone.

15 Jun 2011

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

University of British Columbia researchers - using an innovative, atom-by-atom substitution method - have uncovered the mechanism by which a particular class of drugs controls irregular heartbeats.

15 Jun 2011

immatics initiates IMA901 Phase III trial in renal cell carcinoma

igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.

15 Jun 2011

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Meda presents new positive results from a Phase-III clinical trial of Dymista at the annual meeting of the European Academy of Allergy and Clinical Immunology (EAACI) in Istanbul, Turkey.

15 Jun 2011

Study investigates effects of dopamine replacement therapy on cognition in patients with Parkinson's

Dopamine replacement therapy, which is used to manage motor symptoms associated with Parkinson's disease, can, at times, adversely affect cognition.

15 Jun 2011

Scientists use time-lapse technique to create lab model for ovarian cancer

Scientists at Harvard University have created a laboratory model using time-lapse video microscopic technology that allows observation of early stages of ovarian cancer metastasis.

15 Jun 2011

Bariatric surgery reduces risk of heart attack, stroke or death

Bariatric surgery can cut the incidence of heart attack, stroke or death by as much as 50 percent, according to a new study presented here at the 28th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.

15 Jun 2011

Change in diet can reduce cancer risk

Eating a low-carbohydrate, high-protein diet may reduce the risk of cancer and slow the growth of tumors already present, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

15 Jun 2011

Copper induces protein misfolding, creates fibrillar plaques of Parkinson's disease

Researchers at North Carolina State University have figured out how copper induces misfolding in the protein associated with Parkinson's disease, leading to creation of the fibrillar plaques which characterize the disease.

15 Jun 2011

California adults increase fruit and vegetable consumption from 1997-2007

According to the United States Department of Health and Human Services' Healthy People 2010 objectives, adequate fruit and vegetable consumption is a national public health priority for disease prevention and maintenance of good health.

15 Jun 2011

Wnt signaling may help target hair pigmentation

A new study by researchers at NYU Langone Medical Center has shown that, for the first time, Wnt signaling, already known to control many biological processes, between hair follicles and melanocyte stem cells can dictate hair pigmentation. The study was published in the June 11, 2011 issue of the journal Cell.

15 Jun 2011

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.

15 Jun 2011

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

OCuSOFT, Inc., an ophthalmic pharmaceutical research, development and supply company today announced an exclusive multiyear agreement with Ardeo Health, LLC to distribute a novel dry eye therapy under license from Novagali Pharma S.A. of Evry, France, Nova23041.

15 Jun 2011

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior announced today that it has expanded its nationwide network of high-value, iPhone-connected physicians.

15 Jun 2011

Outpatient gastric bypass surgery linked to increased risk of complications, death

A new study of nearly 52,000 patients found that people who had gastric bypass surgery and were discharged from the hospital sooner than the national average of a two-day length of stay, experienced significantly higher rates of 30-day mortality and complications.

15 Jun 2011

VARI researchers discover protein linked to spread of head and neck cancer nasopharyngeal carcinoma

In a study recently published in Cancer Research, Van Andel Research Institute (VARI) researchers found a protein that could help predict the spread of the head and neck cancer nasopharyngeal carcinoma (NPC); this protein could also serve as part of a treatment strategy to stop the spread of the disease.

15 Jun 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

15 Jun 2011

Prolonged TV viewing associated with higher risk of cardiovascular disease, diabetes and all-cause mortality

In an analysis of data from several studies, watching television for 2-3 hours per day or more was associated with a higher risk of type 2 diabetes, fatal and nonfatal cardiovascular disease and all-cause death, according to a study in the June 15 issue of JAMA.

15 Jun 2011

Medical Condition News

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

ESC publishes position paper to raise the profile of vulnerable plaques

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

immatics initiates IMA901 Phase III trial in renal cell carcinoma

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Study investigates effects of dopamine replacement therapy on cognition in patients with Parkinson's

Scientists use time-lapse technique to create lab model for ovarian cancer

Bariatric surgery reduces risk of heart attack, stroke or death

Change in diet can reduce cancer risk

Copper induces protein misfolding, creates fibrillar plaques of Parkinson's disease

California adults increase fruit and vegetable consumption from 1997-2007

Wnt signaling may help target hair pigmentation

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada

ImpactRx expands nationwide network of high-value, iPhone-connected psychiatrists

Outpatient gastric bypass surgery linked to increased risk of complications, death

VARI researchers discover protein linked to spread of head and neck cancer nasopharyngeal carcinoma

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Prolonged TV viewing associated with higher risk of cardiovascular disease, diabetes and all-cause mortality

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News